DIFFUSE ASTROCYTOMA
Clinical trials for DIFFUSE ASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE ASTROCYTOMA trials appear
Sign up with your email to follow new studies for DIFFUSE ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on brain tumors: first human trial begins
Disease control Recruiting nowThis early-phase study tests an oral drug called ONC206 in 102 adults with brain tumors that have come back or are rare. The main goal is to find the safest dose and understand side effects. Participants take the drug by mouth on a weekly schedule, and researchers monitor for any…
Matched conditions: DIFFUSE ASTROCYTOMA
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
New proton therapy aims to shield Kids' memory during brain tumor treatment
Disease control Recruiting nowThis study tests a special proton therapy technique that avoids the hippocampus, a brain area key for memory, in children with low-grade glioma. The goal is to see if this approach is possible and helps preserve memory and thinking skills over time. About 74 children with certain…
Matched conditions: DIFFUSE ASTROCYTOMA
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
Kids on brain tumor drugs get Long-Term checkup
Disease control Recruiting nowThis study follows children who have already taken dabrafenib and/or trametinib for certain brain tumors. Researchers will monitor side effects and track growth over time. The goal is to understand the long-term safety of these medications in young patients.
Matched conditions: DIFFUSE ASTROCYTOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:10 UTC